New research identifies high-frequency oscillations as potential biomarkers in Alzheimer’s disease, revealing levetiracetam’s differential effects on epileptic and non-epileptic patients.
The effect of levetiracetam, an antiseizure therapy, on high-frequency oscillation in patients with Alzheimer’s disease as ...
High-frequency oscillations in Alzheimer’s may signal seizure risk. Levetiracetam has opposing effects in epileptic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback